The COVID-19 pandemic, caused by SARS-CoV-2, has caused an estimated 5 billion
infections and 20 million deaths by respiratory failure. In addition to the respiratory disease …

Angiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract
several pathophysiological actions of ACE. ACE2 exerts antihypertensive and …

It has been reported that SARS-CoV-2 may use ACE2 as a receptor to gain entry into human
cells, in a way similar to that of SARS-CoV. Analyzing the distribution and expression level of …

Macrophages are key cellular contributors to the pathogenesis of COVID-19, the disease
caused by the virus SARS-CoV-2. The SARS-CoV-2 entry receptor ACE2 is present only on …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have
triggered global pandemic that continue to impact adversely human health. New …

Since being identified as a key receptor for SARS-CoV-2, Angiotensin converting enzyme 2
(ACE2) has been studied as one of the potential targets for the development of preventative …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) utilizes its Spike (S)
glycoprotein to bind to the angiotensin-converting enzyme 2 (ACE2) receptor for cellular …

Abstract Angiotensin-converting enzyme-2 (ACE2) has been recognized as the binding
receptor for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that infects …

CTL-mediated killing of virally infected or malignant cells is orchestrated at the immune
synapse (IS). We hypothesized that SARS-CoV-2 may target lytic IS assembly to escape …

SARS-CoV-2 triggered the most severe pandemic of recent times. To enter into a host cell,
SARS-CoV-2 binds to the angiotensin-converting enzyme 2 (ACE2). However, subsequent …